MedPath

Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy

Completed
Conditions
Head and Neck Neoplasms
Registration Number
NCT02857413
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The aim of this study is the evaluation of the frequency of xerostomia and their management after radiotherapy in head and neck cancer.

The quality of life of these patients is also analysed with European Organization for Research and Treatment of Cancer Quality of life Questionnaire H\&N35 (EORTC QLQ H\&N35).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • patient with head and neck cancer after radiotherapy treatment
Exclusion Criteria
  • patient already treated for xerostomia for other reason : Sjögren's syndrome, medication, diabetes,...

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of xerostomia and their management after radiotherapy in head and neck cancerat enrollment

patients describe the severity of their xerostomia and their management in a standardized questionnaire

Secondary Outcome Measures
NameTimeMethod
quality of life af patients after radiotherapy in head and neck cancerat enrollment

patients describe their quality of life in a standardized questionnaire

Trial Locations

Locations (1)

CHU Besançon

🇫🇷

Besançon, France

© Copyright 2025. All Rights Reserved by MedPath